Shares of Regeneron Pharmaceuticals Inc. slipped 4.06% to $634.14 Tuesday, on what proved to be an all-around favorable ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...

Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $12.1 million in its fourth quarter. The Burlingame, California-based company ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health ...

CROSSJECT enhanced its collaboration with Eton Pharmaceuticals, Inc. ("Eton”) by providing its proprietary innovative hydrocortisone formulation (the "CROSSJECT Formulation”) to enter the hospital ...

The Philippines’ business mission to the Middle East generated $27.28 million in export sales from February 7 to 21.  This achievement marks the first major initiative following the newly signed ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...

Axsome Therapeutics said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder (ADHD) met the main goal in a late-stage study.